Skip to Content

Baell Group

The Baell group consists of experts in Medicinal Chemistry with a focus on the discovery of new treatments for diseases with unmet medical need. The laboratory concentrates on the development of useful drug-leads, pro-drugs and tool compounds, while maintaining effective local and international collaborations with various groups, including commercial partners.

Our group is engaged in a wide variety of fields and topics related to drug development, such as Organic Chemistry, Computational Chemistry, Drug Delivery, Pharmacokinetics & Dynamics and Chemical Biology. Our exciting projects have progressed significantly in the global drug development and medical fields and been included in multiple prestigious academic journal publications, clinical trials and granted patents.

Our team is diverse, vibrant and friendly, with a collective drive to support students in their studies, while progressing individual research projects. With a strong track record of highly qualified graduates of various backgrounds from our group each year, we are indeed experienced in guiding PhD candidates and Research Fellows to reach significant milestones in their careers.

Our work extends from projects with academic interest, towards partnerships with commercial and significant intellectual property interests. We also operate as a part of a Medicinal Chemistry Facility within the Monash Platforms, known as the Australian Translational Medicinal Chemistry Facility (ATMCF). More on this can be found in:

We are also well supported by the Medicinal Chemistry Theme with multiple quality tools and instruments, such as flash chromatography, NMR spectroscopy, liquid chromatography, and mass spectrometers, as well as connections to the HMSTrust Analytical Laboratory (

To aid in progressing our discoveries, we also have long-standing collaborations with all the other Themes within the Faculty of Pharmacy & Pharmaceutical Sciences, such as Drug Discovery Biology (DDB), Drug Delivery, Disposition and Dynamics (D4), and the Centre for Medicine Use and Safety (CMUS); as well as access to the Centre for (CDCO,, and Monash Fragment Platform (MFP,